Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-002827
Filing Date
2024-10-24
Accepted
2024-10-24 17:56:44
Documents
1
Period of Report
2024-10-22

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5331
  Complete submission text file 0000905148-24-002827.txt   7095
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Opus Genetics, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Bennett Jean (Reporting) CIK: 0001872219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 241393673